Your session is about to expire
← Back to Search
Alcohol for Alcoholism (BED IN 36 Trial)
BED IN 36 Trial Summary
This trial will study the effects of alcohol while taking placebo, duloxetine, methylphenidate, and a combination of duloxetine and methylphenidate.
- Alcoholism
BED IN 36 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBED IN 36 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 2 trial • 17 Patients • NCT01779024BED IN 36 Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does the study encompass participants of any age, including those over 55?
"This clinical trial is only open to those aged between 21 and 55. Participants outside of this age range can, however, consider applying for the 50 trials that are available to under-18s or the 286 studies designed for over 65s."
Does the Food and Drug Administration sanction alcohol?
"The safety of alcohol is still largely unknown, so it has been assigned a rating of 1. This assessment reflects the fact that this trial is only at Phase 1 and there are limited clinical data points to support both efficacy and safety."
What is the total participant count of this investigation?
"Affirmative. Data found on clinicaltrials.gov verifies that this trial is actively accepting participants, which started being posted on September 1st 2018 and was last updated on the 23rd of September 2022. In total 48 patients between one location can partake in the experiment."
Are there any opportunities for participants to join this clinical experiment?
"Indeed, the information posted on clinicaltrials.gov points towards this medical trial being open for recruitment. Initially posted on September 1st 2018 and recently updated on September 23rd 2022, it seeks to recruit 48 participants from a single location."
To what extent is enrollment for this trial open?
"This clinical trial is recruiting 48 individuals aged 21 to 55 with a diagnosis of alcoholism. For eligibility, potential participants must also possess the following characteristics: BMI between 19-35; not receiving treatment prior to enrollment; one episode of binge drinking in last 30 days (accordingly 5+ and 4+ drinks for males/females); females using reliable birth control method, who are non-pregnant and not lactating; judged psychiatrically and physically healthy by medical staff; able to abstain from alcohol for 12 hours before sessions begin."
What medicinal benefits are typically associated with Alcohol consumption?
"Alcohol can be an effective treatment for obstructive hypertrophic cardiomyopathy, ethylene glycol poisoning, and Attention Deficit Hyperactivity Disorder (ADHD)."
Share this study with friends
Copy Link
Messenger